Working... Menu

Prospective Study of VEGFR-2 /IL-8 Genetic Interaction in MBC Treated With Paclitaxel and Bevacizumab vs. Chemotherapy (BEVAPROS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02329639
Recruitment Status : Recruiting
First Posted : December 31, 2014
Last Update Posted : October 25, 2017
Information provided by (Responsible Party):
Guido Bocci, University of Pisa